Abstract: The Jones criteria of 2 major criteria or 1 major plus 2 minor criteria that have been classically used to establish the diagnosis have been significantly modified in 2015 by the American Heart Association. The criteria now include the utilization of echocardiography and Doppler color flow mapping as diagnostic tools for carditis, along with defining criteria in relation to overall population risk, delineating low-versus moderate-high risk populations. Monoarthritis and polyarthralgia are now major criteria for moderate-to high-risk groups.
1. Apply the clinical Jones criteria used to make the diagnosis of acute rheumatic fever. 2. Stratify the Jones criteria based on population risk groups. 3. Interpret laboratory testing and diagnostic studies to confirm acute rheumatic fever.
CASE
A 10-year-old Polynesian male sought care in the emergency department for severe left ankle pain. He gave a history that a younger cousin has rolled over his ankle with a tricycle. An x-ray was negative. He was noted to be febrile, but this was attributed to a concurrent viral infection. He was treated with acetaminophen and an elastic wrap. He returned 2 days later with severe pain in his right ankle and foot. This area was extremely tender to touch with very painful range of motion and minimal swelling. His left ankle pain had largely resolved. He was also noted to have a grade 2/6 holosystolic murmur at the apex radiating into his axilla. An electrocardiogram showed a third-degree atrioventricular (AV) block. An echocardiogram confirmed mitral insufficiency with good myocardial contractility and minimal congestive heart failure. His aortic valve was normal. There was no pericardial effusion. His laboratory test results showed a leukocytosis and highly elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). A brain natriuretic peptide assay was highly elevated owing to congestive heart failure. When asked, he did confirm that he had a sore throat 3 weeks ago, but he did not tell his mother about it. He was hospitalized for acute rheumatic fever with mitral valvulitis and congestive heart failure. Streptococcal serologies subsequently returned positive. The positive major criteria were migratory polyarthritis and carditis/valvulitis, and the positive minor criteria were fever, leukocytosis, elevated inflammatory markers. Another related finding but not part of classic Jones criteria was third-degree AV block (classically first-degree AV block is a minor criterion).
Acute rheumatic fever (ARF) is a delayed autoimmune mediated process after infection with group A streptococcus (GAS). Acute rheumatic fever occurs approximately 2 weeks after initial group A strep pharyngitis. Initial presentation includes a spectrum of manifestations, such as carditis, arthritis, chorea, and skin findings. This cluster of manifestations is described as the Jones criteria. Damage to the heart, most commonly valvular inflammation, scarring, and stenosis, can cause lasting effects, known as rheumatic heart disease (RHD), which is a significant cause of morbidity and mortality. 1 The Jones criteria have been used since 1944 for the diagnosis of acute rheumatic fever. Initial modifications were made in 1992, which were reconfirmed in 2000 by the American Heart Association (AHA). 2 The most recent modification to the Jones criteria were made by the AHA in 2015 and include utilization of echocardiography and Doppler color flow mapping as diagnostic tools for carditis, along with defining criteria in relation to overall population risk, delineating low-versus moderate-high risk populations. This statement also assigned for the first time a classification of recommendations and level of evidence according to the AHA classification system. 3 
EPIDEMIOLOGY
The overall incidence of acute rheumatic fever has been declining in most developed countries, including North America and Europe, over the recent decades. 4, 5 This is thought to be attributed to improved access to antibiotics, improved hygiene, reduced overcrowding along with other socioeconomic changes, and possibly shifting GAS serotypes 3, 6 with variable rheumatogenic virulence. Areas with a higher burden of disease typically include areas of poverty and limited resources, such as underdeveloped countries. However, certain indigenous populations within developed countries also see a higher incidence of ARF. 2 For instance, children aged 5 to 14 years of the indigenous populations in Australia have reported one of the highest incidences of ARF in the world, whereas the overall incidence for the country remains on par with North America and Europe. Similarly, the Maori and Pasifika populations of New Zealand living in low resource areas have Pediatric Residents (Rhodes, Rasa) and Professor of Pediatrics (Yamamoto), Department of Pediatrics, University of Hawaii John A. Burns School of Medicine; Pediatric Residents (Rhodes, Rasa) and Chief of Staff and Pediatric Emergency Physician (Yamamoto), Kapi'olani Medical Center for Women and Children, Honolulu, HI. Disclosure: The authors, faculty, and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interest in, any commercial organizations pertaining to this educational activity.
reported a higher incidence of ARF than in non-Maori and nonPasifika children. 1 Higher incidence worldwide has also been reported in Africa, the Pacific basin, South America, Asia, and parts of the Middle East. [7] [8] [9] [10] [11] [12] Acute rheumatic fever is most commonly associated with preceding pharyngitis with the highest incidence in children between 5 and 15 years of age. 13, 14 There is also some controversy surrounding impetigo as a possible cause of acute rheumatic fever and RHD, as areas with a high prevalence of RHD also have a high burden of GAS impetigo and a low incidence of GAS pharyngitis. 15 Even with improvements in detection and early treatment of streptococcal pharyngitis and ARF, 350,000 people per year die from ARF and/or RHD worldwide.
DIAGNOSIS
The Jones criteria are categorized into major and minor criteria. Group A streptococcus infection is required in addition to 2 major or 1 major plus 2 minor criteria, to make a diagnosis of ARF. In the 2015 revision of the Jones Criteria, major criteria differ depending on risk stratification into low-or moderate-to high-risk populations. Low-risk populations are defined as those with an incidence of ARF less than 2 per 100,000 school-aged children, or less than or equal to 1 per 1000 all-age RHD prevalence per year. 3 Prior GAS infection can be proven by (1) increased or rising antistreptolysin O titer, or other streptococcal antibodies; (2) a positive throat culture for group A beta-hemolytic streptococci; and (3) a positive rapid group A streptococcal carbohydrate antigen test in a patient with high probability of streptococcal pharyngitis. 3 According to the current criteria, history or presence of clinically diagnosed scarlet fever is not considered to be sufficient evidence for GAS infection. 16 
Major Criteria
The major criteria for low-risk populations continue to be carditis, polyarthritis, chorea, erythema marginatum, and subcutaneous nodules with the addition/revision that carditis may be clinical and/or subclinical. 3 In contrast, the major criteria for moderate-and high-risk populations have changed to include monoarthritis or polyarthralgia, as replacements for arthritis, and carditis may currently be clinical or subclinical.
Carditis continues to be the most common serious manifestation of ARF, ranging from mild involvement to life-threatening damage.
2 Carditis may involve the endocardium, myocardium, or pericardium, although valvulitis continues to be the most consistent feature. Generally, carditis without valvular involvement is rarely, if ever, considered rheumatic in nature. 3 For example, isolated pericarditis is more likely to be caused by etiologies other than acute rheumatic fever. Traditionally, the diagnosis of valvulitis was made through auscultation of a murmur, usually indicating mitral regurgitation (holosystolic murmur at the apex radiating into the axilla) or aortic valve regurgitation (diastolic murmur heard at the base). However, technologic advances, mainly echocardiography and Doppler flow techniques, have made the diagnosis of carditis possible even in the absence of physical examination findings. This is now considered subclinical carditis and has been included in the diagnostic criteria. 3 The arthritis associated with ARF is typically described as a migratory polyarthritis that most often involves the large joints (knees, ankles, elbows, and wrists). 16 It is generally self-limited even when not treated; however, there is rapid improvement with salicylates or nonsteroidal anti-inflammatory drugs. Several reports have noted aseptic monoarthritis to be an important clinical manifestation in areas with increased incidence of ARF, [17] [18] [19] hence one of the major guideline changes for diagnosis in the 2015 update.
Chorea is described as an involuntary nonrhythmic movement that is sometimes accompanied by concurrent muscular weakness or emotional disturbances. 20, 21 Subcutaneous nodules are firm and painless, and manifest at joint, scalp, and over spinous processes of the thoracic and lumbar spine. Erythema marginatum (Fig. 1 ) is a fairly rare manifestation of ARF. It is a macular pink rash that is blanching with pale clearing and distinct borders. It can appear on the trunk and extremities and rarely involves the face. 2 
Minor Criteria
The minor criteria are also stratified by risk. Low-, moderate-, and high-risk populations all have minor criteria of fever (>38.5°C) and prolonged PR interval, as defined by age-specific norms (if carditis is not otherwise a major criteria for diagnosis). For low-risk populations, other minor criteria include polyarthralgia and ESR of greater than 60 mm/h and/or CRP level of greater than 3.0 mg/dL (ie, above institutional norm). For moderate-and high-risk populations, arthralgia may be monoarticular, ESR is greater than 30 mm/h, and/or CRP level is greater than 3.0 mg/dL. Note that the ESR criteria differ between the groups, but the CRP values do not differ. In addition, joint manifestations, whether arthritis or arthralgia, may only be considered as major or minor criteria but not as both in the same patient. The revised Jones criteria are shown in Table 1 (adapted from the original). 3 
Recurrent Rheumatic Fever
In recurrent rheumatic fever, as seen in Table 1 , 3 minor criteria may be sufficient to make the diagnosis. However, other likely causes that tie together the clinical presentation must be excluded before making the diagnosis of recurrent ARF.
DIFFERENTIAL DIAGNOSIS
The diagnosis of ARF continues to be largely clinical. If a patient meets some but not all of the Jones criteria, alternative diagnoses should be considered.
For a patient presenting with arthritis testing positive for GAS infection, but without further criteria for ARF, consider the diagnosis of poststreptococcal reactive arthritis. Poststreptococcal reactive arthritis is characterized by an additive arthritis of large, small, and axial joints with poor response to nonsteroidal antiinflammatory drug therapy occurring 7 to 10 days after GAS infection. 22 This is thought to be a separate entity from the arthritis of ARF, although it has a similar pathology and it can be associated with carditis. 22 Other considerations include reactive and septic arthritis, juvenile idiopathic arthritis, or other autoimmune/connective tissue disorders. 23 Chorea may have varying differentials including Wilson disease, toxin or drug ingestion, intracranial pathology such as tumor or infection, or autoimmune disorders. 23 One further differential for chorea secondary to GAS infection is pediatric autoimmune neurologic disorder associated with streptococci (PANDAS). This diagnosis is unique because it is immunologically similar to Sydenham chorea seen with ARF through production of antineuronal antibodies but differs slightly in presentation. 24 Pediatric autoimmune neurologic disorder associated with streptococci most commonly presents with abrupt onset of tics, obsessive-compulsive symptoms, and fine choreiform movements usually of the fingers and toes. 25 This is in contrast to the more obvious choreoathetoid involuntary movements of Syndenham chorea.
Alternative diagnoses for carditis without other criteria for ARF may include infective endocarditis, congenital heart disease, or pericarditis secondary to infectious agents or connective tissue disorders. 23 Note that other listed entities in the differential diagnosis such as Lyme disease, Kawasaki disease, and systemic lupus erythematosus all have joint, heart, and skin manifestations. Some of these have brain manifestations as well.
MANAGEMENT
Patients with a high suspicion of ARF are generally hospitalized for further diagnostic evaluation and treatment. The goals of management include the confirmation of the diagnosis (which has long-term implications), eradication of GAS, prophylaxis against reoccurrence of ARF, management of carditis, and symptomatic treatment of arthritis and chorea. 1 Penicillin is the mainstay of treatment and prophylaxis for ARF. Initial treatment with either oral penicillin for a 10-day course or an intramuscular (IM) benzathine penicillin injection is recommended. 1 Generally, IM treatment is preferred over oral treatment because of problems with medication adherence. 26 Prophylaxis with IM benzathine penicillin injections every 3 to 4 weeks should be initiated immediately after treatment. Penicillin prophylaxis is associated with reduced severity of rheumatic valvular lesions over time. 21, 23 The duration of prophylaxis is not standardized and depends on the extent of involvement or severity of illness. The World Health Organization (WHO) gives general guidelines, recommending prophylaxis for 5 years after the last episode or until 18 years of age for patients without carditis, 10 years after the last episode or until at least 25 years of age for patients with mild carditis, or lifelong for those with severe valvular disease and after valvular surgery. 26 Anti-inflammatory medications have long been used for carditis, along with antibiotics, as mentioned above. Aspirin is considered first line therapy according the WHO guidelines, Patients must have evidence of preceding GAS infection For initial ARF:
•
• Carditis (clinical and/or subclinical) • Arthritis (must be polyarthritis)
Minor criteria
Low-risk populations Moderate-and high-risk populations • Polyarthralgia
• Monoarthralgia • Fever >38.5°C
• Fever >38.5°C • ESR >60 mm/h and/or CRP >3.0 mg/dL
• ESR >30 mm/h and/or CRP >3.0 mg/dL • Prolonged PR interval for age (carditis cannot be major criterion)
• Prolonged PR interval for age (carditis cannot be major criterion)
although there is no contemporary evidence to support one form of anti-inflammatory medication over another. Naproxen may offer similar efficacy to aspirin with less adverse effects. 1 Corticosteroids are thought to play a role during acute carditis, especially for patients with moderate-to-severe disease including heart failure, pericardial effusion, or pancarditis. 23 The WHO guidelines recognize oral corticosteroids as a treatment option for those patients with moderate-to-severe disease, and intravenous corticosteroids in lifethreatening circumstances. 26 Other anti-inflammatory options for severe carditis include intravenous immune globulin (IVIG) and adrenocorticotropic hormone. 1 However, a 2015 Cochrane review found no significant evidence to suggest that corticosteroids, IVIG, or aspirin are able to prevent cardiac disease in ARF patients, questioning their role in ARF for carditis. The same review determined that there is no lifesaving role for corticosteroids in patients with RHD. 27 Furthermore, a study comparing oral versus intravenous corticosteroids used in patients with cardiac failure classes III and IV according to the New York Heart Association classification found no significant difference in reducing the course of disease severity between the 2 therapies. 28 Those with cardiac failure should follow typical management with diuretics and vasodilators. Bed rest has also been a mainstay recommendation, although this therapy has also not been proven. 1 For patients with severe carditis with valvular involvement, surgical intervention may be necessary. Surgery during the acute phase is avoided if feasible, as it is associated with poor outcomes. 1 Generally, surgery is required secondary to significant or symptomatic chronic rheumatic valve disease. 26 Valve repair is much preferred over valve replacement if possible. It is usually reserved for patients with lone mitral valve involvement, as success rates are improved and no long-term anticoagulation is necessary 23 ; however, it should be noted that the state of the art of valve replacement is evolving rapidly.
Arthritis is generally managed symptomatically with antiinflammatory drugs.
1 Naproxen and aspirin are most commonly used, although naproxen offers less adverse effects with equivalent efficacy to aspirin. 23 Management of chorea is mainly supportive, unless there is significant motor impairment and interference with daily life. 1 Anticonsvulsant drugs can provide symptomatic relief and are generally well tolerated. Neuroleptics are usually avoided owing to extrapyramidal effects although these were commonly used for treatment in the past. Oral corticosteroids, IVIG, and plasma exchange are also possible treatment options. 23 
PROGNOSIS
The prognosis of patients with ARF and RHD is largely determined by severity and reoccurrence of disease. Resolution of RHD is possible and generally occurs within the first 12 months after the initial episode for patients with mild to moderate carditis. 23 Mitral valve regurgitation alone is the most likely to regress, whereas involvement of the aortic valve rarely shows full resolution. 1 Resolution is dependent upon compliance with penicillin prophylaxis, as poor compliance and reoccurrence increase the risk of complications of RHD and development of chronic RHD. 1 Although mitral and aortic regurgitation may be asymptomatic for years, progression of ARF to RHD, particularly in moderate to severe cases, is related to continued scarring of the valves and/or compensatory dilation of the left ventricle causing further stretching of the mitral and aortic annulus. 1, 29, 30 Rheumatic mitral and aortic stenosis occur secondary to valvular scarring, fibrosis, and calcification, with mitral stenosis associated more with recurrence of disease than with its initial presenting severity. 1 Along with poor compliance and frequent reoccurrences, other factors that predispose patients to chronic RHD are severe carditis and young age with first episode. 1 Chronic RHD increases the patient's risk of complications such as heart failure, infective endocarditis, complications during pregnancy, stroke, arrhythmia, and premature death. 23 
